ELIFE HLDGS: Appointment of Directors and Changes in Board Composition, Suspension Continues

ELIFE HLDGS (00223.HK) announced that, effective March 11, 2025, Tan Xin has been appointed as an executive director; Zhang Zhiling has been appointed as an executive director; Lin Qiucheng has been appointed as an independent non-executive director; Wang Anxin has been appointed as an independent non-executive director; and Hu Guocai has been appointed as an independent non-executive director. On the same day, Qiu Bin, Lin Quanzhi, Huang Zifeng, Chen Xiaodong, Li Zongda, Mei Yihe, Cao Jiarong, Xiang Xin, Zhao Ruiqiang, Zhang Shaoyan, Chen Xinqiong, Chen Weichang, Zhou Zhaohe, Chen Leyan, Ma Jianling, Zhou Deyin, and Yang Qiong (collectively referred to as "former directors") as well as Zhao Zhenzhong, Qin Jiali, and Guo Wei have been removed from their director positions. The company's shares have been suspended from trading on the Stock Exchange since December 2, 2024, and will continue to be suspended until further notice

Source: Finet HK The copyright of this article belongs to the original author/organization.

The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.